Shopping Cart
- Remove All
- Your shopping cart is currently empty
KLS-13019 is a highly effective and orally active GPR55 receptor antagonist, a cannabidiol (CBD)-derived neuroprotective agent that can reverse chemotherapy-induced peripheral neuropathy (CIPN) and is suitable for studying hepatic encephalopathy (HE).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $497 | In Stock | |
5 mg | $1,130 | In Stock |
Description | KLS-13019 is a highly effective and orally active GPR55 receptor antagonist, a cannabidiol (CBD)-derived neuroprotective agent that can reverse chemotherapy-induced peripheral neuropathy (CIPN) and is suitable for studying hepatic encephalopathy (HE). |
Synonyms | KLS13019, KLS 13019 |
Molecular Weight | 355.47 |
Formula | C22H29NO3 |
Cas No. | 1801243-39-9 |
Smiles | C(C)(=C)[C@H]1[C@@H](C=C(C)CC1)C2=C(O)C=C(CC3CN(C(C)=O)C3)C=C2O |
Relative Density. | 1.159 g/cm3 (Predicted) |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.